{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:41:08Z","timestamp":1788932468865,"version":"build-2803163510"},"reference-count":77,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":1017,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB1116"],"award-info":[{"award-number":["SFB1116"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009400","name":"Medical Faculty, Heinrich-Heine-University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1116"],"award-info":[{"award-number":["SFB1116"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009400","name":"Medizinische Fakult\u00e4t, Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>A causal link between non-ischaemic heart failure (HF) and humoral autoimmunity against G-protein-coupled receptors (GPCR) remains unclear except for Chagas' cardiomyopathy. Uncertainty arises from ambiguous reports on incidences of GPCR autoantibodies, spurious correlations of autoantibody levels with disease activity, and lack of standardization and validation of measuring procedures for putatively cardio-pathogenic GPCR autoantibodies. Here, we use validated and certified immune assays presenting native receptors as binding targets. We compared candidate GPCR autoantibody species between HF patients and healthy controls and tested associations of serum autoantibody levels with serological, haemodynamic, metabolic, and functional parameters in HF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ninety-five non-ischaemic HF patients undergoing transcatheter endomyocardial biopsy and 60 healthy controls were included. GPCR autoantibodies were determined in serum by IgG binding to native receptors or a cyclic peptide (for \u03b21AR autoantibodies). In patients, cardiac function, volumes, and myocardial structural properties were assessed by cardiac magnetic resonance imaging; right heart catheterization served for determination of cardiac haemodynamics; endomyocardial biopsies were used for histological assessment of cardiomyopathy and determination of cardiac mitochondrial oxidative function by high-resolution respirometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Autoantibodies against \u03b21 adrenergic (\u03b21AR), M5-muscarinic (M5AR), and angiotensin II type 2 receptors (AT2R) were increased in HF (all P &amp;lt; 0.001). Autoantibodies against \u03b11-adrenergic (\u03b11AR) and angiotensin II type 1 receptors (AT1R) were decreased in HF (all P &amp;lt; 0.001). Correlation of alterations of GPCR autoantibodies with markers of cardiac or systemic inflammation or cardiac damage, haemodynamics, myocardial histology, or left ventricular inflammation (judged by T2 mapping) were weak, even when corrected for total IgG. \u03b21AR autoantibodies were related inversely to markers of left ventricular fibrosis indicated by T1 mapping (r = \u22120.362, P &amp;lt; 0.05) and global longitudinal strain (r = \u22120.323, P &amp;lt; 0.05). AT2R autoantibodies were associated with improved myocardial mitochondrial coupling as measured by high-resolution respirometry in myocardial biopsies (r = \u22120.352, P &amp;lt; 0.05). In insulin-resistant HF patients, AT2R autoantibodies were decreased (r = \u2212.240, P &amp;lt; 0.05), and AT1R autoantibodies were increased (r = 0.212, P &amp;lt; 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GPCR autoantibodies are markedly altered in HF. However, they are correlated poorly or even inversely to haemodynamic, metabolic, and functional markers of disease severity, myocardial histology, and myocardial mitochondrial efficiency. These observations do not hint towards a specific cardio-pathogenic role of GPCR autoantibodies and suggest that further investigations are required before specific therapies directed at GPCR autoantibodies can be clinically tested in non-ischaemic HF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14293","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:18:11Z","timestamp":1675124291000},"page":"1258-1269","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Receptor Autoantibodies: Associations with Cardiac Markers, Histology, and Function in Human Non-Ischaemic Heart Failure"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6739-476X","authenticated-orcid":false,"given":"Elric","family":"Zweck","sequence":"first","affiliation":[{"name":"Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University , D\u00fcsseldorf ,","place":["Germany"]},{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf , M\u00fcnchen-Neuherberg ,","place":["Germany"]},{"name":"Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine University , D\u00fcsseldorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Karschnia","sequence":"additional","affiliation":[{"name":"Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University , D\u00fcsseldorf ,","place":["Germany"]},{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf , M\u00fcnchen-Neuherberg ,","place":["Germany"]},{"name":"Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine University , D\u00fcsseldorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Scheiber","sequence":"additional","affiliation":[{"name":"Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University , D\u00fcsseldorf ,","place":["Germany"]},{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf , M\u00fcnchen-Neuherberg ,","place":["Germany"]},{"name":"Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine University , D\u00fcsseldorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Heidecke","sequence":"additional","affiliation":[{"name":"Cell Trend GmbH , Luckenwalde ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Dechend","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Research Center, University and Max Delbr\u00fcck Center for Molecular Medicine; Departments of Cardiology and Nephrology, Helios Clinic Berlin-Buch , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Barthuber","sequence":"additional","affiliation":[{"name":"Central Institute for Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, Heinrich Heine University and University Hospital , D\u00fcsseldorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine University , D\u00fcsseldorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine University , D\u00fcsseldorf ,","place":["Germany"]},{"name":"Cardiovascular Research Institute D\u00fcsseldorf, Medical Faculty, Heinrich-Heine University , D\u00fcsseldorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roden","sequence":"additional","affiliation":[{"name":"Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University , D\u00fcsseldorf ,","place":["Germany"]},{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf , M\u00fcnchen-Neuherberg ,","place":["Germany"]},{"name":"Cardiovascular Research Institute D\u00fcsseldorf, Medical Faculty, Heinrich-Heine University , D\u00fcsseldorf ,","place":["Germany"]},{"name":"Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University , D\u00fcsseldorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Westenfeld","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine University , D\u00fcsseldorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Szendr\u00f6di","sequence":"additional","affiliation":[{"name":"Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University , D\u00fcsseldorf ,","place":["Germany"]},{"name":"German Center for Diabetes Research (DZD e.V.), Partner D\u00fcsseldorf , M\u00fcnchen-Neuherberg ,","place":["Germany"]},{"name":"Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University , D\u00fcsseldorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Boege","sequence":"additional","affiliation":[{"name":"Central Institute for Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, Heinrich Heine University and University Hospital , D\u00fcsseldorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"2026012114111878600_ehf214293-bib-0001","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2026012114111878600_ehf214293-bib-0002","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2741\/4690","article-title":"GPCR-autoantibodies in chronic heart failure","volume":"23","author":"Boivin-Jahns","year":"2018","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2026012114111878600_ehf214293-bib-0003","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clim.2016.09.003","article-title":"Identification of novel antigens contributing to autoimmunity in cardiovascular diseases","volume":"173","author":"M\u00fcller","year":"2016","journal-title":"Clin Immunol"},{"key":"2026012114111878600_ehf214293-bib-0004","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00392-007-0524-x","article-title":"Autoimmunological features in inflammatory cardiomyopathy","volume":"96","author":"Kallwellis-Opara","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"2026012114111878600_ehf214293-bib-0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08916930008994101","article-title":"Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy","volume":"32","author":"Omerovic","year":"2000","journal-title":"Autoimmunity"},{"key":"2026012114111878600_ehf214293-bib-0006","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ehf2.12744","article-title":"The role of B cells in heart failure and implications for future immunomodulatory treatment strategies","volume":"7","author":"Garc\u00eda-Rivas","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114111878600_ehf214293-bib-0007","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/ehf2.12628","article-title":"The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman pinschers of efficacy and outcomes","volume":"7","author":"Werner","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114111878600_ehf214293-bib-0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201160","article-title":"Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure","volume":"13","author":"Boivin-Jahns","year":"2018","journal-title":"PLoS ONE"},{"key":"2026012114111878600_ehf214293-bib-0009","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ejhf.1461","article-title":"Heart failure in cardiomyopathies: a position paper from the heart failure Association of the European Society of cardiology","volume":"21","author":"Seferovi\u0107","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114111878600_ehf214293-bib-0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12265-020-10025-4","article-title":"A toolbox of potential immune-related therapies for inflammatory cardiomyopathy","volume":"14","author":"Elsanhoury","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"2026012114111878600_ehf214293-bib-0011","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006155","article-title":"beta1-Adrenoreceptor autoantibodies in heart failure: physiology and therapeutic implications","volume":"13","author":"D\u00fcngen","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026012114111878600_ehf214293-bib-0012","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/eurjhf\/hft065","article-title":"Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy","volume":"15","author":"Patel","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026012114111878600_ehf214293-bib-0013","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.2741\/4695","article-title":"Relevant effects of beta1-adrenoceptor autoantibodies in chronic heart failure","volume":"23","author":"Boivin-Jahns","year":"2018","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2026012114111878600_ehf214293-bib-0014","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijcard.2009.11.025","article-title":"Opposing cardiac effects of autoantibody activation of beta-adrenergic and M2 muscarinic receptors in cardiac-related diseases","volume":"148","author":"Stavrakis","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026012114111878600_ehf214293-bib-0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tips.2020.11.013","article-title":"Autoantibodies as endogenous modulators of GPCR signaling","volume":"42","author":"Skiba","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"2026012114111878600_ehf214293-bib-0016","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1476-5381.2012.01828.x","article-title":"Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function","volume":"166","author":"Herda","year":"2012","journal-title":"Br J Pharmacol"},{"key":"2026012114111878600_ehf214293-bib-0017","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/CIRCULATIONAHA.106.683193","article-title":"Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis","volume":"116","author":"Jane-wit","year":"2007","journal-title":"Circulation"},{"key":"2026012114111878600_ehf214293-bib-0018","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.yjmcc.2007.11.007","article-title":"Adoptive passive transfer of rabbit beta1-adrenoceptor peptide immune cardiomyopathy into the Rag2\u2212\/\u2212 mouse: participation of the ER stress","volume":"44","author":"Liu","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"2026012114111878600_ehf214293-bib-0019","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.CIR.99.5.649","article-title":"Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure","volume":"99","author":"Jahns","year":"1999","journal-title":"Circulation"},{"key":"2026012114111878600_ehf214293-bib-0020","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ahj.2006.05.004","article-title":"Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy","volume":"152","author":"St\u00f6rk","year":"2006","journal-title":"Am Heart J"},{"key":"2026012114111878600_ehf214293-bib-0021","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jacc.2009.07.015","article-title":"Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism","volume":"54","author":"Stavrakis","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026012114111878600_ehf214293-bib-0022","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jash.2008.10.004","article-title":"Development of cardiomyopathy and atrial tachyarrhythmias associated with activating autoantibodies to beta-adrenergic and muscarinic receptors","volume":"3","author":"Yu","year":"2009","journal-title":"J Am Soc Hypertens"},{"key":"2026012114111878600_ehf214293-bib-0023","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/eurjhf\/hfs082","article-title":"The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure","volume":"14","author":"Pei","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026012114111878600_ehf214293-bib-0024","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jca.20050","article-title":"Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study","volume":"20","author":"Schimke","year":"2005","journal-title":"J Clin Apher"},{"key":"2026012114111878600_ehf214293-bib-0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.atherosclerosissup.2015.02.023","article-title":"Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus","volume":"18","author":"Dandel","year":"2015","journal-title":"Atheroscler Suppl"},{"key":"2026012114111878600_ehf214293-bib-0026","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40261-020-00903-9","article-title":"A three-part, randomised study to investigate the safety, tolerability, pharmacokinetics and mode of action of BC 007, neutraliser of pathogenic autoantibodies against G-protein coupled receptors in healthy, young and elderly subjects","volume":"40","author":"Becker","year":"2020","journal-title":"Clin Drug Investig"},{"key":"2026012114111878600_ehf214293-bib-0027","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2741\/4698","article-title":"Antibodies against GPCR","volume":"23","author":"Meyer","year":"2018","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2026012114111878600_ehf214293-bib-0028","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2015.09.013","article-title":"Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome","volume":"52","author":"Loebel","year":"2016","journal-title":"Brain Behav Immun"},{"key":"2026012114111878600_ehf214293-bib-0029","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07598-9","article-title":"GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis","volume":"9","author":"Cabral-Marques","year":"2018","journal-title":"Nat Commun"},{"key":"2026012114111878600_ehf214293-bib-0030","doi-asserted-by":"crossref","first-page":"16609","DOI":"10.18632\/aging.103864","article-title":"Autoantibodies against M5-muscarinic and beta1-adrenergic receptors in periodontitis patients","volume":"12","author":"Scherbaum","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"2026012114111878600_ehf214293-bib-0031","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2362.2010.02314.x","article-title":"Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies","volume":"40","author":"Trimpert","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"2026012114111878600_ehf214293-bib-0032","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/clpt.2009.246","article-title":"Fcgamma-receptor IIa polymorphism and the role of immunoadsorption in cardiac dysfunction in patients with dilated cardiomyopathy","volume":"87","author":"Staudt","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"2026012114111878600_ehf214293-bib-0033","article-title":"Measurement of antibody effects on cellular function of isolated cardiomyocytes","volume":"73","author":"Eckerle","year":"2013","journal-title":"J Vis Exp: JoVE"},{"key":"2026012114111878600_ehf214293-bib-0034","first-page":"254","article-title":"Activating autoantibodies and cardiovascular disease","volume":"28","author":"Luft","year":"2013","journal-title":"Physiology (Bethesda)"},{"key":"2026012114111878600_ehf214293-bib-0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijcard.2015.10.068","article-title":"Detection of DCM-associated beta1-adrenergic receptor autoantibodies requires functional readouts or native human beta1-receptors as targets","volume":"202","author":"Bornholz","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012114111878600_ehf214293-bib-0036","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jacc.2017.03.617","article-title":"beta1AAb determined by peptide ELISA: a signal in the noise?","volume":"70","author":"Boege","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012114111878600_ehf214293-bib-0037","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000376546","article-title":"Questionable validity of petide-based ELISA strategies in the diagnostics of cadrdiopathogenic autoantibodies that activate G-protein-coupled receptors","volume":"131","author":"Jahns","year":"2015","journal-title":"Cardiology"},{"key":"2026012114111878600_ehf214293-bib-0038","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/ehf2.12747","article-title":"Unmasking features of the auto-epitope essential for beta1 -adrenoceptor activation by autoantibodies in chronic heart failure","volume":"7","author":"W\u00f6lfel","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114111878600_ehf214293-bib-0039","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ehjci\/jex230","article-title":"T2 mapping cardiovascular magnetic resonance identifies the presence of myocardial inflammation in patients with dilated cardiomyopathy as compared to endomyocardial biopsy","volume":"19","author":"Spieker","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012114111878600_ehf214293-bib-0040","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026012114111878600_ehf214293-bib-0041","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s12276-019-0214-6","article-title":"High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure","volume":"51","author":"Scheiber","year":"2019","journal-title":"Exp Mol Med"},{"key":"2026012114111878600_ehf214293-bib-0042","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12265-018-9803-3","article-title":"Reduced myocardial mitochondrial ROS production in mechanically unloaded hearts","volume":"12","author":"Scheiber","year":"2018","journal-title":"J Cardiovasc Transl Res"},{"key":"2026012114111878600_ehf214293-bib-0043","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.2337\/db18-0449","article-title":"Insulin resistance and vulnerability to cardiac ischemia","volume":"67","author":"Jelenik","year":"2018","journal-title":"Diabetes"},{"key":"2026012114111878600_ehf214293-bib-0044","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCRESAHA.116.307974","article-title":"T1 mapping in characterizing myocardial disease: a comprehensive review","volume":"119","author":"Puntmann","year":"2016","journal-title":"Circ Res"},{"key":"2026012114111878600_ehf214293-bib-0045","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart \u2014 an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"2026012114111878600_ehf214293-bib-0046","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/cvr\/10.6.613","article-title":"Effect of chagasic sera on the rat isolated atrial preparation: immunological, morphological and function aspects","volume":"10","author":"Sterin-Borda","year":"1976","journal-title":"Cardiovasc Res"},{"key":"2026012114111878600_ehf214293-bib-0047","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0091-6749(84)90227-6","article-title":"Anti-receptor antibodies in human disease","volume":"74","author":"Fraser","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"2026012114111878600_ehf214293-bib-0048","first-page":"S634","article-title":"Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes","volume":"46","author":"Wallukat","year":"1987","journal-title":"Biomed Biochim Acta"},{"key":"2026012114111878600_ehf214293-bib-0049","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.RES.64.1.97","article-title":"Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy","volume":"64","author":"Limas","year":"1989","journal-title":"Circ Res"},{"key":"2026012114111878600_ehf214293-bib-0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0167-5273(96)02589-2","article-title":"Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathy","volume":"54","author":"Fu","year":"1996","journal-title":"Int J Cardiol"},{"key":"2026012114111878600_ehf214293-bib-0051","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10741-010-9211-5","article-title":"Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine","volume":"17","author":"Munoz-Saravia","year":"2012","journal-title":"Heart Fail Rev"},{"key":"2026012114111878600_ehf214293-bib-0052","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-4939-9148-8_19","article-title":"Analytics of functional autoantibodies in patients with Chagas disease","volume":"1955","author":"Wallukat","year":"2019","journal-title":"Methods Mol Biol"},{"key":"2026012114111878600_ehf214293-bib-0053","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1515\/cclm-2015-0603","article-title":"A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of beta1-adrenergic receptor autoantibodies in human heart disease","volume":"54","author":"Bornholz","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"2026012114111878600_ehf214293-bib-0054","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phrs.2017.07.008","article-title":"AT2 receptors in cardiovascular and renal diseases","volume":"125","author":"Kaschina","year":"2017","journal-title":"Pharmacol Res"},{"key":"2026012114111878600_ehf214293-bib-0055","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/HYPERTENSIONAHA.115.05428","article-title":"AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction","volume":"66","author":"Liles","year":"2015","journal-title":"Hypertension"},{"key":"2026012114111878600_ehf214293-bib-0056","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","article-title":"AT1 receptor signaling pathways in the cardiovascular system","volume":"125","author":"Kawai","year":"2017","journal-title":"Pharmacol Res"},{"key":"2026012114111878600_ehf214293-bib-0057","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2741\/4709","article-title":"Functional autoantibody diseases: basics and treatment related to cardiomyopathies","volume":"24","author":"Becker","year":"2019","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2026012114111878600_ehf214293-bib-0058","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cvr\/cvs350","article-title":"Impact of human autoantibodies on beta1-adrenergic receptor conformation, activity, and internalization","volume":"97","author":"Bornholz","year":"2013","journal-title":"Cardiovasc Res"},{"key":"2026012114111878600_ehf214293-bib-0059","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijcard.2016.03.032","article-title":"Impact of common beta-adrenergic receptor polymorphisms on the interaction with agonistic autoantibodies in dilated cardiomyopathy","volume":"214","author":"Bornholz","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012114111878600_ehf214293-bib-0060","doi-asserted-by":"crossref","DOI":"10.1038\/srep32430","article-title":"Proliferation in cardiac fibroblasts induced by beta1-adrenoceptor autoantibody and the underlying mechanisms","volume":"6","author":"Lv","year":"2016","journal-title":"Sci Rep"},{"key":"2026012114111878600_ehf214293-bib-0061","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/europace\/euu228","article-title":"M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation","volume":"17","author":"Gurses","year":"2015","journal-title":"EP Europace"},{"key":"2026012114111878600_ehf214293-bib-0062","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1071-9164(99)90009-X","article-title":"Active immunization of combined beta1-adrenoceptor and M2-muscarinic receptor peptides induces cardiac hypertrophy in rabbits","volume":"5","author":"Matsui","year":"1999","journal-title":"J Card Fail"},{"key":"2026012114111878600_ehf214293-bib-0063","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.881208","article-title":"Compensatory upregulation of anti-beta-adrenergic receptor antibody levels might prevent heart failure presentation in pediatric myocarditis","volume":"10","author":"Seidel","year":"2022","journal-title":"Front Pediatr"},{"key":"2026012114111878600_ehf214293-bib-0064","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1381.1999.99220.x","article-title":"Free fatty acids, insulin resistance, and type 2 diabetes mellitus","volume":"111","author":"Boden","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"2026012114111878600_ehf214293-bib-0065","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00125-016-3977-5","article-title":"The angiotensin II type 2 receptor agonist compound 21 is protective in experimental diabetes-associated atherosclerosis","volume":"59","author":"Chow","year":"2016","journal-title":"Diabetologia"},{"key":"2026012114111878600_ehf214293-bib-0066","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mce.2012.05.017","article-title":"Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act","volume":"378","author":"Muniyappa","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"2026012114111878600_ehf214293-bib-0067","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-61779-382-0_3","article-title":"High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle","volume":"810","author":"Pesta","year":"2012","journal-title":"Methods Mol Biol"},{"key":"2026012114111878600_ehf214293-bib-0068","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1055\/s-2001-18576","article-title":"Insulin resistance: definition and consequences","volume":"109","author":"Lebovitz","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026012114111878600_ehf214293-bib-0069","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"2026012114111878600_ehf214293-bib-0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048387","article-title":"Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARgamma activation","volume":"7","author":"Ohshima","year":"2012","journal-title":"PLoS ONE"},{"key":"2026012114111878600_ehf214293-bib-0071","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8917578","article-title":"Update on RAAS modulation for the treatment of diabetic cardiovascular disease","volume":"2016","author":"Bernardi","year":"2016","journal-title":"J Diabetes Res"},{"key":"2026012114111878600_ehf214293-bib-0072","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.2337\/dc20-2255","article-title":"Exposure to type 2 diabetes provokes mitochondrial impairment in apparently healthy human hearts","volume":"44","author":"Zweck","year":"2021","journal-title":"Diabetes Care"},{"key":"2026012114111878600_ehf214293-bib-0073","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"2026012114111878600_ehf214293-bib-0074","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012114111878600_ehf214293-bib-0075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2213-8587(14)70031-2","article-title":"Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored","volume":"2","author":"McMurray","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026012114111878600_ehf214293-bib-0076","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/08916930701619235","article-title":"Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy","volume":"41","author":"Caforio","year":"2008","journal-title":"Autoimmunity"},{"key":"2026012114111878600_ehf214293-bib-0077","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1191\/0961203305lu2193oa","article-title":"Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies","volume":"14","author":"Caforio","year":"2005","journal-title":"Lupus"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.14293","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.14293","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/2\/1258\/65051138\/eschf_10_2_1258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/2\/1258\/65051138\/eschf_10_2_1258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:12:39Z","timestamp":1769022759000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/2\/1258\/8304876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":77,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1,30]]},"published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14293","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4]]},"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"2022-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}